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Abstract 
Introduction: Zika virus is transmitted mainly through the bites of infected Aedes 
mosquitoes, although mother-to-child and sexual transmission have also been 
described. The presence of zika virus in semen after infection seems to be not 
uncommon, but the duration of viral persistence is not well determined.   
Methods: We used molecular, serological and cell culture methods for the diagnosis 
and follow up of a case of zika virus infection imported from Venezuela. Serial samples 
of serum, urine and semen were analyzed to investigate zika virus persistence.   
Results: zika virus was detected in semen samples up to 93 days after the onset of 
symptoms. 
Conclusions: Our results confirm persistence of zika virus in semen samples for long 
periods after infection 
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Resumen 
Introducción: El virus zika se transmite fundamentalmente por la picadura de 
mosquitos Aedes infectados, aunque también es posible la transmisión de madre a hijo 
y la transmisión sexual. La presencia del virus Zika en semen tras la infección parece 
ser algo relativamente frecuente, pero la duración de la persistencia viral no es bien 
conocida. 
Métodos: Mediante técnicas moleculares, serológicas y cultivo celular se diagnóstico 
un caso de zika importado de Venezuela y se tomaron muestra seriadas de suero, orina 
y semen para investigar la persistencia del virus 
Resultados: El virus zika fue detectado en muestras de semen recogidas 93 días 
después del inicio de los síntomas 
Conclusiones: Nuestros resultados confirman la persistencia del virus zika en semen 
por períodos prolongados de tiempo después de la infección 
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Case report 
In January 2016 a man in his 30s, previously diagnosed with prostatitis in December 
2015 and in treatment with ciprofloxacin, presented to the Tropical Medicine 
Department at Hospital Clinic (Barcelona) two days after his return from a 15-day 
holiday trip to Venezuela. During his stay he reported self-limited hematospermia and 
ceftibuten was added by a local urologist to his previous ciprofloxacin regime. In the 
trip back to Europe he started with malaise, fever (≥ 39°C), myalgias, arthralgias and 
retro-orbital pain. One day after, he developed a total itchy body macular rash, 
followed by conjunctivitis. He had not been vaccinated for this trip. He had received 
yellow fever vaccination in the past and referred dengue fever infection during his 
childhood. Medical examination revealed bilateral enlarged latero cervical lymph 
nodes, non purulent conjuntivitis and an intense itchy maculopapular rash diffused on 
the face, trunk, arms and legs. He had mild transaminitis (alanine aminotransferase 
195 UI/L, aspartate aminotransferase 79 UI/L) and elevated C-reactive protein (1.69 
mg/dl). A complete blood count, blood levels of electrolytes, as well as coagulation and 
renal-function tests were normal. Chest radiograph results were unremarkable. The 
fever and the cutaneous rash resolved in 3 days while malaise, weakness, and myalgia 
lasted for 1 week after presentation.  
 
Laboratory investigations 
Diagnosis of zika virus (ZIKV) infection was established by real time reverse-
transcription polymerase chain reaction (RT-PCR) using a commercial kit (RealStar Zika 
Virus RT-PCR Kit 1.0, Altona Diagnostics, Hamburg, Germany) in a serum sample 
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collected three days post onset of illness (dpi). Dengue and chikungunya RNA were not 
detected by specific real-time RT-PCR assays and malaria was ruled out by negative 
blood thick and thin smears. The presence of ZIKV was confirmed by Sanger 
sequencing analysis of a 270 bp amplicon (from a generic flavivirus RT-PCR assay1) of 
the NS5 gene. The patient agreed to provide follow up samples to investigate the 
presence of ZIKV in semen, serum and urine samples. A summary of the samples 
collected and the results obtained is shown in Table 1. No ZIKV RNA was detected in 
follow up serum or urine samples. The first semen sample was obtained at 30 dpi and 
tested positive by ZIKV real time RT-PCR. Two more semen samples obtained at 51 and 
93 dpi also contained detectable levels of ZIKV RNA. A fourth semen sample collected 
201 dpi tested negative for ZIKV. For cell culture, semen samples were kept frozen 
until inoculated onto Vero cells and monitored for virus growth by visual inspection 
of the cytopathic effect and by RT-PCR of culture supernatants, but the virus could 
not be isolated. Serological tests were performed for dengue (Panbio ELISA, Alere, 
Australia), chikungunya and zika (Immunofluorescence, Euroimmun, Germany). The 
patient tested positive for IgG against dengue upon first presentation at the Hospital, 
in agreement with the dengue virus infection he reported to have suffered during his 
childhood. This first sample tested positive for IgG against zika by immunofluorescence 
but was negative by Anti-Zika Virus ELISA (Euroimmun, Germany), in concordance with 
the higher specificity reported for the ELISA test
2
. IgM against zika was positive one 
month after onset of symptoms and was undetectable 2 months later. 
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Discussion 
ZIKV is, to date, the only flavivirus transmitted through sexual contact, and this mode 
of transmission might be more frequent than previously thought. So far, male to male 
3
, male to female 
4,5
 and female to male sexual transmission 
6
 have been documented 
and up to 11 countries have reported ZIKV sexual transmission. While most cases have 
been originated from men with previous history of ZIKV symptoms, the virus can also 
be spread through sexual contact before the symptoms develop and even from 
asymptomatic ZIKV infections 
7
. ZIKV sexual transmission is of public health concern, 
particularly for pregnant women given the possibility of ZIKV induced fetal 
abnormalities 
8
.  
The duration of ZIKV persistence in semen is yet poorly understood. Reports of 
travelers that acquired ZIKV during the present American epidemic showed viral 
persistence in semen for 47, 62, 76 and 80 days.  Recently, a case of Zika Virus 
persistence for 6 months in semen has been described in a traveler returning from 
Haiti to Italy
9
. In our case, ZIKV infection imported from Venezuela was confirmed 
during the viremic period 3 days after the onset of symptoms. Results of the follow up 
samples suggest that viral persistence was restricted to semen and longer shedding in 
urine was not demonstrated. Although it is possible to isolate ZIKV from semen, our 
attempts were not successful. Failure to isolate ZIKV from semen samples has been 
reported in other studies
9
, with even higher viral loads (lower Ct) than in our case. The 
RT-PCR Cycle Treshold (Ct) values obtained in the three positive semen samples 
remained relatively stable until the last positive sample was tested as long as 93 days 
after the onset of symptoms. Our results confirm longer periods for ZIKV presence in 
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semen and represent, to our knowledge, the first reported follow up of zika virus in 
semen in Spain. Unfortunately, samples between the third and the sixth month after 
symptomatic illness were not available for testing. We can only suggest that 
somewhere between 93 and 201 dpi ZIKV RNA declined to undetectable levels. Current 
recommendations include a precautionary period of safer sex/abstinence for 6 months 
after onset of illness or for 8 weeks in asymptomatic patients who traveled to areas 
with active ZIKV transmission 
10,11
. This distinction between symptomatic and 
asymptomatic patients has, to our knowledge, no scientific basis to support that viral 
persistence in semen of asymptomatic patients is shorter than in symptomatic ZIKV 
infections. Further studies are needed to better characterize the frequency and 
duration of ZIKV persistence in semen. For other emerging viruses such as Ebola, the 
duration of the virus in semen has been expanding as long as new studies and larger 
series of patients have been analyzed, moving from 91 days in the Kikwit outbreak 
12
 to 
18 months in the West African epidemic 
13
. Likewise, factors influencing viral 
persistence in semen should be identified for a better understanding of ZIKV kinetics in 
humans. 
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Introduction: Zika virus is transmitted mainly through the bites of infected Aedes 
mosquitoes, although mother-to-child and sexual transmission have also been 
described. The presence of zika virus in semen after infection seems to be not 
uncommon, but the duration of viral persistence is not well determined.   
Methods: We used molecular, serological and cell culture methods for the diagnosis 
and follow up of a case of zika virus infection imported from Venezuela. Serial samples 
of serum, urine and semen were analyzed to investigate zika virus persistence.   
Results: zika virus was detected in semen samples up to 93 days after the onset of 
symptoms. 
Conclusions: Our results confirm persistence of zika virus in semen samples for long 
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Resumen 
Introducción: El virus zika se transmite fundamentalmente por la picadura de 
mosquitos Aedes infectados, aunque también es posible la transmisión de madre a hijo 
y la transmisión sexual. La presencia del virus Zika en semen tras la infección parece 
ser algo relativamente frecuente, pero la duración de la persistencia viral no es bien 
conocida. 
Métodos: Mediante técnicas moleculares, serológicas y cultivo celular se diagnóstico 
un caso de zika importado de Venezuela y se tomaron muestra seriadas de suero, orina 
y semen para investigar la persistencia del virus 
Resultados: El virus zika fue detectado en muestras de semen recogidas 93 días 
después del inicio de los síntomas 
Conclusiones: Nuestros resultados confirman la persistencia del virus zika en semen 
por períodos prolongados de tiempo después de la infección 
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Case report 
In January 2016 a man in his 30s, previously diagnosed with prostatitis in December 
2015 and in treatment with ciprofloxacin, presented to the Tropical Medicine 
Department at Hospital Clinic (Barcelona) two days after his return from a 15-day 
holiday trip to Venezuela. During his stay he reported self-limited hematospermia and 
ceftibuten was added by a local urologist to his previous ciprofloxacin regime. In the 
trip back to Europe he started with malaise, fever (≥ 39°C), myalgias, arthralgias and 
retro-orbital pain. One day after, he developed a total itchy body macular rash, 
followed by conjunctivitis. He had not been vaccinated for this trip. He had received 
yellow fever vaccination in the past and referred dengue fever infection during his 
childhood. Medical examination revealed bilateral enlarged latero cervical lymph 
nodes, non purulent conjuntivitis and an intense itchy maculopapular rash diffused on 
the face, trunk, arms and legs. He had mild transaminitis (alanine aminotransferase 
195 UI/L, aspartate aminotransferase 79 UI/L) and elevated C-reactive protein (1.69 
mg/dl). A complete blood count, blood levels of electrolytes, as well as coagulation and 
renal-function tests were normal. Chest radiograph results were unremarkable. The 
fever and the cutaneous rash resolved in 3 days while malaise, weakness, and myalgia 
lasted for 1 week after presentation.  
 
Laboratory investigations 
Diagnosis of zika virus (ZIKV) infection was established by real time reverse-
transcription polymerase chain reaction (RT-PCR) using a commercial kit (RealStar Zika 
Virus RT-PCR Kit 1.0, Altona Diagnostics, Hamburg, Germany) in a serum sample 
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collected three days post onset of illness (dpi). Dengue and chikungunya RNA were not 
detected by specific real-time RT-PCR assays and malaria was ruled out by negative 
blood thick and thin smears. The presence of ZIKV was confirmed by Sanger 
sequencing analysis of a 270 bp amplicon (from a generic flavivirus RT-PCR assay
1
) of 
the NS5 gene. The patient agreed to provide follow up samples to investigate the 
presence of ZIKV in semen, serum and urine samples. A summary of the samples 
collected and the results obtained is shown in Table 1. No ZIKV RNA was detected in 
follow up serum or urine samples. The first semen sample was obtained at 30 dpi and 
tested positive by ZIKV real time RT-PCR. Two more semen samples obtained at 51 and 
93 dpi also contained detectable levels of ZIKV RNA. A fourth semen sample collected 
201 dpi tested negative for ZIKV. For cell culture, semen samples were kept frozen 
until inoculated onto Vero cells and monitored for virus growth by visual inspection of 
the cytopathic effect and by RT-PCR of culture supernatants, but the virus could not be 
isolated. Serological tests were performed for dengue (Panbio ELISA, Alere, Australia), 
chikungunya and zika (Immunofluorescence, Euroimmun, Germany). The patient 
tested positive for IgG against dengue upon first presentation at the Hospital, in 
agreement with the dengue virus infection he reported to have suffered during his 
childhood. This first sample tested positive for IgG against zika by immunofluorescence 
but was negative by Anti-Zika Virus ELISA (Euroimmun, Germany), in concordance with 
the higher specificity reported for the ELISA test
2
. IgM against zika was positive one 
month after onset of symptoms and was undetectable 2 months later. 
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Discussion 
ZIKV is, to date, the only flavivirus transmitted through sexual contact, and this mode 
of transmission might be more frequent than previously thought. So far, male to male 
3
, male to female 
4,5
 and female to male sexual transmission 
6
 have been documented 
and up to 11 countries have reported ZIKV sexual transmission. While most cases have 
been originated from men with previous history of ZIKV symptoms, the virus can also 
be spread through sexual contact before the symptoms develop and even from 
asymptomatic ZIKV infections 
7
. ZIKV sexual transmission is of public health concern, 
particularly for pregnant women given the possibility of ZIKV induced fetal 
abnormalities 
8
.  
The duration of ZIKV persistence in semen is yet poorly understood. Reports of 
travelers that acquired ZIKV during the present American epidemic showed viral 
persistence in semen for 47, 62, 76 and 80 days.  Recently, a case of Zika Virus 
persistence for 6 months in semen has been described in a traveler returning from 
Haiti to Italy
9
. In our case, ZIKV infection imported from Venezuela was confirmed 
during the viremic period 3 days after the onset of symptoms. Results of the follow up 
samples suggest that viral persistence was restricted to semen and longer shedding in 
urine was not demonstrated. Although it is possible to isolate ZIKV from semen, our 
attempts were not successful. Failure to isolate ZIKV from semen samples has been 
reported in other studies
9
, with even higher viral loads (lower Ct) than in our case. The 
RT-PCR Cycle Treshold (Ct) values obtained in the three positive semen samples 
remained relatively stable until the last positive sample was tested as long as 93 days 
after the onset of symptoms. Our results confirm longer periods for ZIKV presence in 
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semen and represent, to our knowledge, the first reported follow up of zika virus in 
semen in Spain. Unfortunately, samples between the third and the sixth month after 
symptomatic illness were not available for testing. We can only suggest that 
somewhere between 93 and 201 dpi ZIKV RNA declined to undetectable levels.  
Current recommendations include a precautionary period of safer sex/abstinence for 6 
months after onset of illness or for 8 weeks in asymptomatic patients who traveled to 
areas with active ZIKV transmission 
10,11
. This distinction between symptomatic and 
asymptomatic patients has, to our knowledge, no scientific basis to support that viral 
persistence in semen of asymptomatic patients is shorter than in symptomatic ZIKV 
infections. Further studies are needed to better characterize the frequency and 
duration of ZIKV persistence in semen. For other emerging viruses such as Ebola, the 
duration of the virus in semen has been expanding as long as new studies and larger 
series of patients have been analyzed, moving from 91 days in the Kikwit outbreak 
12
 to 
18 months in the West African epidemic 
13
. Likewise, factors influencing viral 
persistence in semen should be identified for a better understanding of ZIKV kinetics in 
humans. 
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Laboratory tests
Real time RT-PCR 3 30 48
ZIKV (Serum)
Positive 
(28.7)
Negative
ZIKV (Urine) Negative
ZIKV (Semen)
Positive 
(31.4)
Positive 
(32.58)
DENV (serum) Negative
CHIKV (serum) Negative
Serology 
IgM ZIKV Negative Positive
IgG ZIKV Positive (*) Positive
IgM DENV Negative Positive
IgG DENV Positive Positive
IgM CHIKV Negative Negative
IgG CHIKV Negative Negative
Days post onset of illness
Tablas (Tables)
